2020
Europe’s project RESCEU sheds new light on the fight against the Respiratory Syncytial Virus (RSV) and its economic impact
2020
Big achievements in the RECOVER project: on April 22nd the first patient was enrolled in the “Household transmission study” – part of the RECOVER project- aimed at investigating the spread of SARS-CoV-2 infection within households, that represents one of the main factors that drives the pandemic.
To find out more on how RECOVER is using a COVapp to guide participants on this study and on other important achievements read the RECOVER press release.
2020
Antwerp, Belgium – 11 March, 2020
The University of Antwerp has launched Rapid European COVID-19 Emergency Research response (RECOVER), in collaboration with 9 international partners. The launch comes in response to the impact of the novel Coronavirus (COVID-19) epidemic in Europe. This project was selected for funding by the European Union under the Horizon 2020 research framework and builds on many years of investment by the European Commission in clinical research preparedness for epidemic response.
2020
Antwerp, Belgium – 3 March 2020
The EU-funded Platform foR European Preparedness Against (Re-) emerging Epidemics (PREPARE) has decided to upgrade its response efforts to the novel Coronavirus (SARS-CoV-2) epidemic to Outbreak Research Response Mode 3, the highest response mode. This means that PREPARE will immediately initiate and implement clinical research studies on SARS-CoV-2 across Europe, it has been preparing for over the last month.
2020
Antwerp, Belgium – 24 February 2020
Confirmed SARS-CoV-2 infected patients have been reported in Europe for several weeks now and PREPARE has been monitoring developments very closely.
With ongoing clusters in Iran, South Korea, Singapore, Thailand, Vietnam, Hong Kong, Japan and more recently in Italy, we anticipate further large clusters and possibly community-wide transmission in Europe and therefore are preparing our clinical research response accordingly.
2020
Antwerp, Belgium – 6 February 2020
On 30th January 2020, the Director General of the World Health Organisation (WHO) declared the outbreak of 2019-nCoV a public health emergency of international concern. The Platform foR European Preparedness Against (Re-) emerging Epidemics (PREPARE) has now mobilized to mode 2 response activity, representing an important next level of preparedness for the actual conduct of clinical research in the event of further 2019-nCoV spread in Europe.
2019
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019
The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitrodiagnostic companies who join forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. The purpose of VALUE-Dx is to transform medical practice to achieve more personalised,